Regulation of B Lymphocyte Proliferation by Antigen
Project Number5R01AI020038-25
Contact PI/Project LeaderDEFRANCO, ANTHONY L
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
The fate of B cells is highly dependent on signals from the B cell antigen receptor (BCR) for development,
tolerance, and activation decisions. The overall goal of this project is to understand the role of cholesterol-
rich subdomains of the plasma membrane called lipid rafts in BCR signal transduction. Recent work in B
cells has established that lipid rafts play a role in BCR signaling. Lipid rafts exist primarily as small, highly
dynamic structures that coalesce into larger and more stable lipid rafts upon cell stimulation. BCR
stimulation leads to its movement from the non-lipid raft plasma membrane into lipid rafts and induces
coalescence of lipid rafts, eventually leading to a large lipid raft patch or cap on the cell surface. In Specific
Aim 1, the mechanism of BCR-induced lipid raft coalescence will be studied. BCR stimulation causes ezrin
to become dephosphorylated and to release its connection between some lipid raft proteins and the actin
cytoskeleton. We shall test if this release promotes lipid raft coalescence and BCR signaling. We
hypothesize that the later stages of lipid raft coalescence require active processes involving myosins and will
attempt to identify the myosin isoform responsible. BCR stimulation also leads to outgrowth of long filopdia-
like projections ("cytonemes") and in Specific Aim 2, we shall determine the mechanism of outgrowth of
these projections. We shall explore the role of the B144 protein, the Rac1 and Cdc42 GTPases, and myosin
10 and its close relatives. In Specific Aim 3, we shall examine the connection of lipid rafts to the ability of the
BCR to activate the key transcription factor, NF-kB. Carmal, a key scaffold molecule for this signaling
pathway, is localized to lipid rafts and it recruits other components of this pathway to lipid rafts following BCR
stimulation. The importance of Carmal localization to lipid rafts and of lipid raft coalescence for activation of
NF-kB will be determined. Finally, in Specific Aim 4, we shall examine lipid raft coalescence and NF-kB
pathway activation in immature B cells and B cell lines' of immature phenotype, which appear to differ from
mature B cells in these processes. .
Lay Language Statement: The ability of the immune system to respond to infectious agents depends on the
function of the antigen receptors of lymphocytes. This function appears to involve changes in a subdomain
of the plasma membrane called lipid rafts and the mechanisms of these changes will be studied.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
094878337
UEI
KMH5K9V7S518
Project Start Date
01-January-1984
Project End Date
30-November-2010
Budget Start Date
01-December-2008
Budget End Date
30-November-2009
Project Funding Information for 2009
Total Funding
$360,779
Direct Costs
$238,138
Indirect Costs
$122,641
Year
Funding IC
FY Total Cost by IC
2009
National Institute of Allergy and Infectious Diseases
$360,779
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI020038-25
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI020038-25
Patents
No Patents information available for 5R01AI020038-25
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI020038-25
Clinical Studies
No Clinical Studies information available for 5R01AI020038-25
News and More
Related News Releases
No news release information available for 5R01AI020038-25
History
No Historical information available for 5R01AI020038-25
Similar Projects
No Similar Projects information available for 5R01AI020038-25